University of Milano-Bicocca
Clinical Trials
119
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (42 trials with phase data)• Click on a phase to view related trials
Machine Learning Applied to EHRs Data of Patients With Sarcoma
- Conditions
- SarcomaOsteosarcomaEwing Sarcoma
- First Posted Date
- 2025-10-10
- Last Posted Date
- 2025-10-10
- Lead Sponsor
- University of Milano Bicocca
- Target Recruit Count
- 700
- Registration Number
- NCT07215728
Bicocca Epidemiological Assessment of Cardiovascular Risk Factors
- Conditions
- Cardiovascular Risk Factors (e.g., Hypertension)
- First Posted Date
- 2025-10-06
- Last Posted Date
- 2025-10-06
- Lead Sponsor
- University of Milano Bicocca
- Target Recruit Count
- 1000
- Registration Number
- NCT07207603
- Locations
- 🇮🇹
University of Milan-Bicocca, Milan, Italy
Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network
- Conditions
- Chronic Myeloid Leukemia (CML)
- First Posted Date
- 2025-09-10
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- University of Milano Bicocca
- Target Recruit Count
- 2000
- Registration Number
- NCT07165535
- Locations
- 🇮🇹
Fondazione IRCCS San Gerardo dei Tintori, Monza, MB, Italy
Self-care Behaviors of Type 2 Diabetes Mellitus Patients
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- University of Milano Bicocca
- Target Recruit Count
- 300
- Registration Number
- NCT07042399
- Locations
- 🇮🇹
IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy
🇮🇹Fondazione IRCCS San Gerardo dei Tintori, Monza, Monza Brianza, Italy
Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence
- Conditions
- Prostate Cancer (Post Prostatectomy)
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-10-03
- Lead Sponsor
- University of Milano Bicocca
- Target Recruit Count
- 50
- Registration Number
- NCT06941363
- Locations
- 🇮🇹
Radiation Oncology, Fondazione IRCCS San Gerardo dei Tintori (University of Milan Bicocca), Monza, Italy, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 24
- Next
News
Ponatinib Shows Superior Survival Outcomes in Ph+ ALL Patients with Persistent MRD After Induction
Post hoc analysis of the PhALLCON trial demonstrates that ponatinib achieved higher rates of deep molecular responses compared to imatinib in newly diagnosed Ph+ ALL patients who remained MRD-positive after induction therapy.